Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells
- PMID: 27815690
- DOI: 10.1007/s12015-016-9695-z
Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells
Abstract
Mesenchymal stem cells (MSC) have been extensively studied over the past years for the treatment of different diseases. Most of the ongoing clinical trials currently involve the use of MSC derived from adult tissues. This source may have some limitations, particularly with therapies that may require extensive and repetitive cell dosage. However, nowadays, there is a staggering growth in literature on a new source of MSC. There is now increasing evidence about the mesenchymal differentiation from pluripotent stem cell (PSC). Here, we summarize the current knowledge of pluripotent-derived mesenchymal stem cells (PD-MSC). We present a historical perspective on the subject, and then discuss some critical questions that remain unanswered.
Keywords: Cell reprogramming; Differentiation; EMT; Embryonic stem cells; Epithelial-to-mesenchymal transition; Mesenchymal stem cells; Mesenchymal stromal cells; Pluripotent stem cells; Pluripotent-derived mesenchymal stem cells; iPS-derived mesenchymal stem cells.
Similar articles
-
Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming.Int J Mol Sci. 2019 Apr 18;20(8):1922. doi: 10.3390/ijms20081922. Int J Mol Sci. 2019. PMID: 31003536 Free PMC article. Review.
-
Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.Stem Cells Transl Med. 2018 May;7(5):439-449. doi: 10.1002/sctm.17-0260. Epub 2018 Feb 28. Stem Cells Transl Med. 2018. PMID: 29489062 Free PMC article.
-
Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.Stem Cells. 2012 Jan;30(1):42-7. doi: 10.1002/stem.727. Stem Cells. 2012. PMID: 21898694 Free PMC article. Review.
-
Hypoxia enhances buffalo adipose-derived mesenchymal stem cells proliferation, stemness, and reprogramming into induced pluripotent stem cells.J Cell Physiol. 2019 Aug;234(10):17254-17268. doi: 10.1002/jcp.28342. Epub 2019 Feb 25. J Cell Physiol. 2019. PMID: 30805934
-
Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question.Curr Stem Cell Res Ther. 2012 May;7(3):191-6. doi: 10.2174/157488812799859865. Curr Stem Cell Res Ther. 2012. PMID: 22329581 Review.
Cited by
-
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment.Mol Neurobiol. 2021 Jul;58(7):3494-3514. doi: 10.1007/s12035-021-02324-x. Epub 2021 Mar 21. Mol Neurobiol. 2021. PMID: 33745116 Free PMC article. Review.
-
Different isoforms of growth hormone (20 kD-GH and 22 kD-GH) shows different biological activities in mesenchymal stem cell (MSC).Cell Cycle. 2022 May;21(9):934-947. doi: 10.1080/15384101.2022.2035491. Epub 2022 Feb 19. Cell Cycle. 2022. PMID: 35188065 Free PMC article.
-
Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA.Int J Mol Sci. 2019 Apr 3;20(7):1648. doi: 10.3390/ijms20071648. Int J Mol Sci. 2019. PMID: 30987077 Free PMC article.
-
Dedifferentiated fat cells: current applications and future directions in regenerative medicine.Stem Cell Res Ther. 2023 Aug 21;14(1):207. doi: 10.1186/s13287-023-03399-0. Stem Cell Res Ther. 2023. PMID: 37605289 Free PMC article. Review.
-
Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration.Bioeng Transl Med. 2023 Nov 29;9(2):e10629. doi: 10.1002/btm2.10629. eCollection 2024 Mar. Bioeng Transl Med. 2023. PMID: 38435815 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous